FindTrial
Sign In

The Role and Clinical Significance of DNA Methylation of Junctional Adhesion Molecule 3 (JAM3) in the Development and Progression of Laryngeal Squamous Cell Carcinoma

The Role and Clinical Significance of DNA Methylation of Junctional Adhesion Molecule 3 (JAM3) in the Development and Progression of Laryngeal Squamous Cell Carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081169
Enrollment
Unknown
Registered
2024-02-26
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Squamous Cell Carcinoma

Interventions

TUMOR :NA
MARGIN:NA

Sponsors

First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 100 Years

Inclusion criteria

Inclusion criteria: ?A newly diagnosed patient undergoing laryngeal squamous cell carcinoma operation in the Department of Otolaryngology and Head and Neck Surgery, the First Hospital of Shanxi Medical University; ? The pathological diagnosis was squamous cell carcinoma; ?Volunteer to enroll and sign informed consent for clinical study.

Exclusion criteria

Exclusion criteria: ? The tissue is small, difficult to collect or insufficient for the detection of relevant indicators; ? Hepatitis, syphilis, tuberculosis, HIV and other infectious diseases; ?Non-onset patients or those who have already received other treatments; ?Clinical data are incomplete; ?Loss to follow-up.

Design outcomes

Primary

MeasureTime frame
The expression level of JAM3;—

Secondary

MeasureTime frame
The methylation status of JAM3;—

Countries

China

Contacts

Public ContactHui Huangfu

First Hospital of Shanxi Medical University

huangfu_hui@163.com+86 182 0341 0054

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026